J. Brian Stalter

Special Counsel
Full contact info

Passions

Hiking

History Books

Games of all kinds

Experience

Immatics Announces Collaboration With Moderna

September 11, 2023

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its strategic collaboration with Moderna.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Stephanie Parker Palmer
Special Counsel, Reston
J. Brian Stalter
Special Counsel, New York
Carly Robinson
Associate, Reston
David D. Suh
Associate
Freddy Yip
Associate, Hong Kong
Jacqueline Grise
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Rubin Waranch
Associate, Washington DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Stella Sarma
Special Counsel, Brussels
Jan Lang
Associate, Brussels
Kimberly Nguyen
Special Counsel, Reston
Liza Hadley
Associate, Boston
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Matthew Pavao
Partner, Boston

Related Practices & Industries

Senti Biosciences Sells Certain Assets to Celadon Partners

August 14, 2023

Cooley advised Senti Biosciences, a biotechnology company, on its sale of certain assets – including its manufacturing facility and chemistry, manufacturing, and controls capabilities – to Celadon Partners.

Read more

Related contacts

Maureen Nagle
Special Counsel, Washington DC
Luke X. Blackett
Associate, San Francisco
Chrystal Cantrelle
Associate, Washington DC
Rena Kaminsky
Special Counsel, Palo Alto
Freddy Yip
Associate, Hong Kong
Peter Crain
Special Counsel, Reston
Alanna B Zuchelli
Associate, Reston
Ross Eberly
Partner, Los Angeles Santa Monica
Marya Postner
Partner, Palo Alto
Helen Luu
Associate, Palo Alto
Aric Wu
Partner, New York
Rachel Thorn
Partner, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Christopher Kimball
Partner, Washington DC
Dee Bansal
Partner, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Stacey A. Bradford
Special Counsel, Washington DC
J. Brian Stalter
Special Counsel, New York
Annie Froehlich
Special Counsel, Washington DC
Amanda Pacheco
Associate, Palo Alto
Zack Gong
Associate, Shanghai
Nicholas Balenger
Associate, Reston
Rachel Boyce
Associate, San Francisco
Ajay Athavale
Associate, San Francisco
Sarah Oliai
Associate, Washington DC
Leina Verrier
Associate, Los Angeles Santa Monica
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Cooley Advises Quell Therapeutics on its Exclusive Treg Collaboration With AstraZeneca

June 9, 2023

Cooley advised Quell Therapeutics, a leading T-regulatory (Treg) cell therapy biotech company based in London, on its exclusive collaboration with AstraZeneca.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Frances Stocks Allen
Partner, London
Tom Goodman
Partner, London
Jiqiang Lin
Associate, New York
J. Brian Stalter
Special Counsel, New York
Ellen Dewhurst
Associate, London

Related Practices & Industries

Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb

December 22, 2021

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its license, development and commercialization agreement with Bristol Myers Squibb for its TCR bispecific candidate, IMA401. Lawyers Ken Krisko, Carly Robinson, Brian Stalter and Stephanie Palmer led the Cooley team advising Immatics.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Carly Robinson
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Stephanie Parker Palmer
Special Counsel, Reston
Nicollette R. Kirby
Associate, Washington DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Jan Lang
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Patrick Van Eecke
Partner, Brussels
Bartholomäus Regenhardt
Associate, Brussels
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma

October 13, 2021

Cooley advised Otsuka Pharmaceutical, a global healthcare company, on its worldwide collaboration and license agreement with biopharmaceutical company Sunovion Pharmaceuticals and parent company Sumitomo Dainippon Pharma for the joint development and commercialization of four novel candidate compounds. Lawyers Alison Freeman-Gleason and Brian Stalter led the Cooley team advising Otsuka.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle
J. Brian Stalter
Special Counsel, New York
Jacqueline Grise
Partner, Washington DC
David Burns
Special Counsel, Washington DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Georgina Dietrich
Associate, Brussels
Jan Lang
Associate, Brussels
Marc Suskin
Partner, New York

Related Practices & Industries